logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Tuberculosis

    FiltersReset Filters
    12 results
    • azithromycin

      (AZITHROMYCIN)
      Alembic Pharmaceuticals Inc.
      Usage: Azithromycin tablets are indicated for treating mild to moderate infections caused by specific susceptible microorganisms and for the prophylaxis and treatment of disseminated Mycobacterium avium complex disease in persons with advanced HIV infection. Use should be limited to infections proven or suspected to be caused by susceptible bacteria.
    • azithromycin

      (AZITHROMYCIN)
      Alembic Pharmaceuticals Limited
      Usage: Azithromycin is a macrolide antibacterial indicated for treating mild to moderate infections from susceptible microorganisms. It is also used for prophylaxis and treatment of disseminated Mycobacterium avium complex disease in individuals with advanced HIV infection. Usage should aim to reduce drug resistance in bacteria.
    • clarithromycin

      (Clarithromycin)
      Sandoz Inc
      Usage: Clarithromycin tablets are indicated for treating mild to moderate infections in adults and children, including acute bacterial exacerbations of chronic bronchitis, acute maxillary sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin infections, acute otitis media, and for eradicating Helicobacter pylori in duodenal ulcer disease.
    • clarithromycin

      (Clarithromycin)
      Ajanta Pharma USA Inc.
      Usage: Clarithromycin tablets are indicated for treating mild to moderate infections in adults and pediatric patients, including acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin infections, acute otitis media, disseminated mycobacterial infections, and H. pylori infections.
    • clarithromycin

      (Clarithromycin)
      Alembic Pharmaceuticals Limited
      Usage: Clarithromycin tablets are indicated for treating mild to moderate infections in adults and pediatric patients, including acute bacterial exacerbations of chronic bronchitis, acute maxillary sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin infections, acute otitis media, mycobacterial infections in HIV, and H. pylori infections.
    • erythromycin

      (Erythromycin)
      Torrent Pharmaceuticals Limited
      Usage: Erythromycin tablets are indicated for treating infections caused by susceptible bacteria, including upper and lower respiratory tract infections, listeriosis, pertussis, diphtheria, and skin infections. They are also used for prophylaxis against rheumatic fever in penicillin-allergic patients and treating certain Chlamydia infections.
    • isoniazid

      (Isoniazid)
      Chartwell RX, LLC
      Usage: Isoniazid oral solution is indicated for treating all forms of tuberculosis caused by susceptible organisms and as preventive therapy for high-risk groups, including HIV-infected individuals, close contacts of infectious TB, recent converters, and those with abnormal chest radiographs or other medical conditions increasing TB risk.
    • ofloxacin

      (OFLOXACIN)
      Cadila Pharmaceuticals Limited
      Usage: Ofloxacin is indicated for treating or preventing infections in adults caused by susceptible bacteria, including acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, uncomplicated skin infections, gonorrhea, and urinary tract infections. It should be reserved for specific cases due to potential serious adverse effects.
    • pamidronate disodium

      (PAMIDRONATE DISODIUM)
      Hospira, Inc.
      Usage: Pamidronate disodium is indicated for treating moderate to severe hypercalcemia of malignancy, Paget's disease, and osteolytic bone metastases from breast cancer and multiple myeloma. It is used alongside hydration and standard antineoplastic therapies, demonstrating significant biochemical and clinical benefits in affected patients.
    • rifampin

      (rifampin)
      Lupin Pharmaceuticals, Inc.
      Usage: Rifampin is indicated for treating all forms of tuberculosis and eliminating Neisseria meningitidis in asymptomatic carriers. It is not recommended for meningococcal infections. Therapy requires susceptibility testing due to rapid resistance development. Treatment should be adjusted based on culture results and patient response, especially in high-risk scenarios.